Biotech

All Articles

A more detailed take a look at Fierce Biotech's Strong 15

.Within this week's incident of "The Best Pipe," our experts are actually diving in to Strong Biotec...

Lilly encounters stage 2 failing of tau-targeting med

.The confetti is still flying from Eli Lilly's gathering celebrating the approval of Alzheimer's hea...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of considerable management hirings, shootings an...

Lykos are going to ask FDA to reconsider its decision adhering to denial of MDMA therapy for post-traumatic stress disorder

.Complying with an inadequate revealing for Lykos Therapies' MDMA applicant for trauma at a recent F...

AN 2 fifty percents headcount, quits phase 3 test after records disappoint

.AN2 Therapies is actually reconsidering its own service in feedback to poor midphase data, promisin...

Merck spends $700M for bispecific, spying autoimmune opening as well as opportunity to challenge Amgen in cancer cells

.Merck &amp Co. is actually paying out $700 thousand in advance to challenge Amgen in a blood stream...

Gilead pays out J&ampJ $320M to go out licensing deal for seladelpar

.Along With Gilead Sciences on the verge of an FDA selection for its own liver illness medication se...

' All palms on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks can see the business putting together outdoors tents at basecam...

Entero giving up personnel, vacating workplace and also stopping briefly R&ampD

.Bed mattress Liquidators has actually turned Entero Therapeutics white as a slab. The lender got En...

Exelixis drops ADC after deciding it's no match for Tivdak

.Exelixis is giving up on its own cells variable (TF)- targeting antibody-drug conjugate after concl...